<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-cinacalcet.xml</id>
  <title>Recalls Watch: Cinacalcet</title>
  <link rel="self" href="https://recalls.watch/feed/substance-cinacalcet.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-10-28T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/100087/</id>
    <title>STRIDES PHARMA INC: Cinacalcet Tablets</title>
    <link href="https://recalls.watch/recall/fda/100087/"/>
    <updated>2026-10-28T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed dissolution specifications</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99350/</id>
    <title>Cipla USA, Inc.: Cinacalcet Hydrochloride Tablets and 2 more</title>
    <link href="https://recalls.watch/recall/fda/99350/"/>
    <updated>2026-07-08T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99077/</id>
    <title>Amgen, Inc.: Corlanor and 4 more</title>
    <link href="https://recalls.watch/recall/fda/99077/"/>
    <updated>2026-07-01T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Substance. CGMP Deviations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98670/</id>
    <title>Cipla USA, Inc.: Cinacalcet Hydrochloride Tablets and 2 more</title>
    <link href="https://recalls.watch/recall/fda/98670/"/>
    <updated>2026-04-22T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97974/</id>
    <title>Cipla USA, Inc.: Cinacalcet Hydrochloride Tablets and 2 more</title>
    <link href="https://recalls.watch/recall/fda/97974/"/>
    <updated>2025-12-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97215/</id>
    <title>Strides Pharma, Inc.: Cinacalcet Tablets 90 mg</title>
    <link href="https://recalls.watch/recall/fda/97215/"/>
    <updated>2025-08-06T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Dissolution Specifications.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96433/</id>
    <title>Slate Run Pharmaceuticals: Cinacalcet Hydrochloride Tablets 30 mg and 1 more</title>
    <link href="https://recalls.watch/recall/fda/96433/"/>
    <updated>2025-03-26T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95897/</id>
    <title>AvKARE: Cinacalcet Tablets and 2 more</title>
    <link href="https://recalls.watch/recall/fda/95897/"/>
    <updated>2024-12-11T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95730/</id>
    <title>Aurobindo Pharma USA Inc: Cinacalcet Tablets and 2 more</title>
    <link href="https://recalls.watch/recall/fda/95730/"/>
    <updated>2024-12-11T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95501/</id>
    <title>ACCORD HEALTHCARE, INC.: Cinacalcet Tablets 30 mg and 2 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=95501"/>
    <updated>2024-11-06T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95500/</id>
    <title>Dr. Reddy's Laboratories, Inc.: Cinacalcet Tablets and 2 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=95500"/>
    <updated>2024-11-06T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93820/</id>
    <title>SUN PHARMACEUTICAL INDUSTRIES INC: Cinacalcet Tablets 60mg and 10 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93820"/>
    <updated>2024-01-31T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.</summary>
  </entry>
</feed>
